Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

60.0%

3 terminated/withdrawn out of 5 trials

Success Rate

25.0%

-61.5% vs industry average

Late-Stage Pipeline

40%

2 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2
1(25.0%)
N/A
1(25.0%)
Phase 3
1(25.0%)
Phase 4
1(25.0%)
4Total
Phase 2(1)
N/A(1)
Phase 3(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT04239261Phase 2Terminated

Serum-derived Bovine Immunoglobulin Effect on Mucositis

Role: lead

NCT03230240Unknown

Immunologic Profile of Peritoneal Cancer

Role: lead

NCT04266288Phase 4Completed

Effectiveness of Ketamine for Depression and Suicidal Ideation in the Emergency Department

Role: lead

NCT02523911Not ApplicableWithdrawn

Efficacy and Tolerability of Suprep With and Without Simethicone for Routine Colonoscopy for Colorectal Cancer Screening

Role: lead

NCT02102555Phase 3Terminated

Acetaminophen vs Placebo in the Pre-operative Setting and Outcomes on Post-operative Pain, Nausea and Vomiting

Role: lead

All 5 trials loaded